VREOF (Vireo Growth) Growth Rank : 0 (As of Oct. 31, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Vireo Growth Growth Rank?

Vireo Growth has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Vireo Growth Growth Rank Related Terms

Thank you for viewing the detailed overview of Vireo Growth's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Vireo Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (OTCPK:VREOF) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

0ZF:Germany VREO:Canada

Address

207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402

Website

https://www.vireogrowth.com

Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs.

Executives

Chicago Atlantic Credit Opportunities, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Manager, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Gp Holdings, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group, Lp	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group Gp, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Advisers, Llc	10 percent owner	420 NORTH WABASH AVENUE, SUITE 500, CHICAGO IL 60611
Joshua Rosen	director	207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Victor E. Mancebo	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Christian Gonzales Ocasio	officer: Chief Operating Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Amber Holly Shimpa	director, officer: Chief Administrative Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Patrick Peters	officer: EVP of Retail	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
J Michael Schroeder	officer: General Counsel & CCO	3680 VICTORA STREET N, SHOREVIEW MN 55126
John Andrew Heller	officer: Chief Financial Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Ross Michael Hussey	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Judd Theodore Nordquist	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402